Mariner, LLC Exact Sciences Corp Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Mariner, LLC holds 27,085 shares of EXAS stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,085

Previous 31,586 14.25%

Holding current value

$1.57 Million

Previous $1.33 Million 38.23%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $190,977 - $318,805	-4,501 Reduced 14.25%	27,085 $1.84 Million
Q2 2024 Aug 13, 2024	SELL	$41.33 - $74.26 $73,856 - $132,702	-1,787 Reduced 5.35%	31,586 $1.33 Million
Q1 2024 May 15, 2024	SELL	$56.27 - $73.77 $133,303 - $174,761	-2,369 Reduced 6.63%	33,373 $2.3 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $58,587 - $75,114	-992 Reduced 2.7%	35,742 $2.64 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $304,049 - $456,673	4,611 Added 14.35%	36,734 $2.51 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $169,486 - $257,015	2,704 Added 9.19%	32,123 $3.02 Million
Q1 2023 May 12, 2023	BUY	$47.19 - $70.77 $13,543 - $20,310	287 Added 0.99%	29,419 $1.99 Million
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $153,115 - $268,141	-5,045 Reduced 14.76%	29,132 $1.44 Million
Q3 2022 Nov 10, 2022	SELL	$31.97 - $49.37 $21,451 - $33,127	-671 Reduced 1.93%	34,177 $1.11 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $39,811 - $85,225	1,118 Added 3.31%	34,848 $1.37 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $3,914 - $5,612	68 Added 0.2%	33,730 $2.36 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $653,515 - $907,529	-9,014 Reduced 21.12%	33,662 $2.62 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $1.49 Million - $2.05 Million	16,537 Added 63.27%	42,676 $4.07 Million
Q2 2021 Aug 24, 2021	BUY	$93.66 - $139.27 $74,834 - $111,276	799 Added 3.15%	26,139 $3.25 Million
Q1 2021 May 07, 2021	BUY	$116.57 - $155.01 $1.54 Million - $2.05 Million	13,208 Added 108.87%	25,340 $3.34 Million
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $6,972 - $9,948	70 Added 0.58%	12,132 $1.61 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $108,140 - $151,280	-1,483 Reduced 10.95%	12,062 $1.23 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $755,133 - $1.26 Million	13,545 New	13,545 $1.18 Million
Q3 2019 Nov 13, 2019	SELL	$90.37 - $122.49 $517,187 - $701,010	-5,723 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $61,135 - $80,621	683 Added 13.55%	5,723 $676,000
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $28,262 - $44,004	-456 Reduced 8.3%	5,040 $437,000
Q4 2018 Feb 13, 2019	BUY	$56.04 - $82.66 $307,995 - $454,299	5,496 New	5,496 $347,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account